Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study.
about
Interventions for preventing oral mucositis for patients with cancer receiving treatmentInterventions for preventing oral mucositis for patients with cancer receiving treatmentAmifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancerResults of a planned interim toxicity analysis with trimodality therapy, including carboplatin AUC = 4, paclitaxel, 5-fluorouracil, amifostine, and radiation for locally advanced esophageal cancer: preliminary analyses and treatment recommendationsNovel drugs to ameliorate gastrointestinal normal tissue radiation toxicity in clinical practice: what is emerging from the laboratory?Effect of amifostine in head and neck cancer patients treated with radiotherapy: a systematic review and meta-analysis based on randomized controlled trialsComparison of acute toxicities in two primary chemoradiation regimens in the treatment of advanced head and neck squamous cell carcinoma.Protective activity of a novel resveratrol analogue, HS-1793, against DNA damage in 137Cs-irradiated CHO-K1 cells.Radiation-Induced Oral MucositisTHE POTENTIATION OF THE RADIOPROTECTIVE EFFICACY OF TWO MEDICAL COUNTERMEASURES, GAMMA-TOCOTRIENOL AND AMIFOSTINE, BY A COMBINATION PROPHYLACTIC MODALITY.Sensitivity of salivary glands to radiation: from animal models to therapiesAlpha-2-macroglobulin as a radioprotective agent: a reviewConcurrent administration of Docetaxel and Stealth liposomal doxorubicin with radiotherapy in non-small cell lung cancer : excellent tolerance using subcutaneous amifostine for cytoprotection.Civilian nuclear incidents: An overview of historical, medical, and scientific aspectsOral mucositis: time for more studies.Novel strategies to ameliorate radiation injury: a possible role for tetrahydrobiopterinProtective Effect of Lycium ruthenicum Murr. Against Radiation Injury in MiceTocotrienol-Rich Fraction from Rice Bran Demonstrates Potent Radiation Protection ActivityCASE REPORT Removal of Exposed Titanium Reconstruction Plate After Mandibular Reconstruction With a Free Fibula Osteocutaneous Flap With Large Surgical Pin Cutters: A Case Report and Literature Review.Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in Quality of Life measured by EPIC score.Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses.Alternate delivery route for amifostine as a radio-/chemo-protecting agent.Post-radiation dental index: development and reliabilityAmifostine protects vascularity and improves union in a model of irradiated mandibular fracture healing.Evaluation of current and upcoming therapies in oral mucositis prevention.Molecular hydrogen and radiation protection.Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics?Systematic review of amifostine for the management of oral mucositis in cancer patients.Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy.Survey of Policies and Guidelines on Antioxidant Use for Cancer Prevention, Treatment, and Survivorship in North American Cancer Centers: What Do Institutions Perceive as Evidence?Radio-protective effect and mechanism of 4-Acetamido-2,2,6,6- tetramethylpiperidin-1-oxyl in HUVEC cells.RRx-001 protects against cisplatin-induced toxicities.Sustained-release microspheres of amifostine for improved radio-protection, patient compliance, and reduced side effects.Sesamol ameliorates radiation induced DNA damage in hematopoietic system of whole body γ-irradiated mice.[Effect of amifostine on locally advanced non-small cell lung cancer patients treated with radiotherapy: a meta-analysis of randomized controlled trials].
P2860
Q24235217-9A1A3123-630C-4F5D-BF0E-12D11553A04CQ24235482-870742C2-879E-444D-8E85-9FE98D80D8EFQ24240711-22FC2427-4CE0-4755-99D8-0B0E4E7C0000Q24797816-7873918C-F51C-4AC4-AC6A-6A6EAA1A0B32Q26823881-A6C10C6E-F066-4B07-BFB0-BA3D0CFB6E9FQ28538411-2D548D1A-296B-439D-A07D-D726E104BCC0Q33399402-94ACC6C6-C49E-43C3-9E2D-DE6C06FD1AFDQ33582639-45949721-03CD-4554-9AC9-87A829080C13Q33711362-A776E75B-1CA0-425A-85C7-76534DCEF6CCQ33728050-F1E5F4B6-D461-4F9E-A23A-5B7DA81774C9Q33901931-4A937413-ACBA-452E-B2F2-51EA7DDCCCD4Q34452752-95874592-F7DD-4CCF-BCFA-A12A4E55953FQ34785152-35AA7B79-21EA-435B-8801-E70ECC193A3EQ35093930-32C11E6E-F5B3-4199-BCFA-67F1D71484DCQ35173183-9DE63535-109B-49BD-98EB-2AB12A180C15Q35848552-6BEF6228-0BBF-4814-8801-FE41B8E95175Q35891063-1E8069D4-78EC-4739-9706-3C0E34A3BBDBQ36070511-F84F1638-3225-43E0-A66A-DE21BFFCC845Q36204648-9E79A3AE-0584-42BF-B293-EEAB6F9F96F4Q36495325-2BAA11C3-042A-43F3-AE62-6391F566740AQ36544184-669921C3-D170-4617-8E0C-11F08AF2A18CQ37189789-4B858AE1-032B-4D42-9A65-32F474CE8D68Q37259248-BB2209EE-6883-4C1F-AD9D-98E86352518BQ37378457-48502F45-ACB5-419B-92B1-01E419571321Q37818225-B5732607-1E3A-4494-9E82-21235DDFC211Q38005799-84FD1B65-2F78-4B58-8F8D-3D7973F869E6Q38019401-15314B84-E1D8-4406-B24A-523DEA0D3193Q38050986-231592A4-E2C8-4DDC-8804-EA5FC106410DQ38651513-6B24E3BE-4ED9-4C6E-A998-A016728E8C45Q43429878-5397240A-0B76-4BBA-9293-200D8BDA0C05Q45834119-377BF628-2B02-4644-8A15-4DA3EB8DB30BQ46154170-EA214B1F-B942-41E0-B7CE-2A4E41C833ECQ50223842-075F2681-4F0F-43AD-B86A-06D161231602Q51832847-11B72CE4-3689-4C87-8366-A756A76C26B9Q55429590-1DEE910D-6B05-48C3-92BC-1D93DFE05959
P2860
Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Subcutaneous administration of ...... : a randomized phase II study.
@en
type
label
Subcutaneous administration of ...... : a randomized phase II study.
@en
prefLabel
Subcutaneous administration of ...... : a randomized phase II study.
@en
P2093
P1476
Subcutaneous administration of ...... : a randomized phase II study.
@en
P2093
A Giatromanolaki
C Frangiadaki
C Kouroussis
M I Koukourakis
S Kakolyris
V Georgoulias
P304
P356
10.1200/JCO.2000.18.11.2226
P407
P577
2000-06-01T00:00:00Z